SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd is trending due to heightened geopolitical tensions in the Middle East, with the community actively discussing the potential for global oil supply disruption through the Strait of Hormuz to drive energy prices higher and trigger a short squeeze.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is surging amid escalating geopolitical tensions in the Middle East and strong financial performance, including a recent agreement to quadruple THAAD missile production and an upbeat outlook. The community is keenly discussing the 'war effect' driving a 'defense super-cycle,' even as some express caution about the stock's rapid run.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as heightened geopolitical tensions are driving conversation around defense technology, with the community closely watching its participation in the Drone Dominance Gauntlet and anticipating updates from its upcoming Innovation Day.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund (XLE) is under intense focus as escalating geopolitical tensions, including US-Israel strikes on Iran and severe disruption to tanker traffic in the Strait of Hormuz, ignite expectations for a substantial oil price surge. The community is actively debating the potential for crude to reach $100 or even higher, driving a significant rotation into the energy sector amidst concerns of a prolonged supply shock from the critical chokepoint.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is trending as escalating geopolitical tensions in the Middle East, specifically concerning Iran and the Strait of Hormuz, are driving a significant surge in oil prices. The community is highly engaged, anticipating substantial gains for the energy sector amidst potential supply disruptions, while others express caution regarding the sustainability of the rally.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp. is experiencing a surge as escalating geopolitical tensions in the Middle East fuel speculation of an oil supply shock, with the community actively discussing its low float and high short interest for a potential short squeeze if the conflict intensifies.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending amid notable downward pressure, driven by broader financial sector weakness and geopolitical concerns, as community discussions weigh its strong fundamentals and potential S&P 500 inclusion against fears of further declines and dilution rumors.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending amidst escalating geopolitical tensions impacting global LNG supplies from the Middle East, with the community anticipating a significant short squeeze and strong financial results from its expanding production and new long-term contracts.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is a major talking point as investors debate whether escalating Middle East conflict and rising oil prices will significantly boost EV demand or if the high-flying stock's valuation, combined with skepticism over its robotaxi future, makes it vulnerable to a market downturn.

RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA.

RTX Corp

Raytheon Technologies Corporation

RTX is trending amid escalating global tensions, driving robust community discussion around increased defense spending and the company's pivotal role in supplying advanced missile systems like Tomahawk and Patriot. The market is actively anticipating a strong upside for defense stocks, with RTX at the forefront of this renewed geopolitical focus.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Rating Upgraded by Zacks Research

Zacks Research upgraded shares of MoonLake Immunotherapeutics from a "strong sell" rating to a "hold" rating in a research report on Tuesday...

MoonLake Immunotherapeutics (NASDAQ:MLTX) Posts Earnings Results

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.97) earnings per share (EPS) for the quarter, meeting the...

Lifesci Capital Has Optimistic Outlook of MLTX Q4 Earnings

MoonLake Immunotherapeutics (NASDAQ:MLTX - Free Report) - Stock analysts at Lifesci Capital raised their Q4 2025 EPS estimates for shares of MoonLake Immunotherapeutics in a report released on...

Needham & Company LLC Issues Positive Forecast for MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Price

Needham & Company LLC increased their price objective on shares of MoonLake Immunotherapeutics from $20.00 to $25.00 and gave the stock a "buy" rating in a research note on Monday...

MoonLake Immunotherapeutics (NASDAQ:MLTX) Price Target Raised to $30.00

BTIG Research increased their price objective on MoonLake Immunotherapeutics from $24.00 to $30.00 and gave the stock a "buy" rating in a report on Monday...

MoonLake Immunotherapeutics Investor Day: HS BLA on Track, axSpA Phase 2 Data Highlights Imaging Wins

MoonLake Immunotherapeutics (NASDAQ:MLTX) used its Investor Day presentation to outline updates across its clinical portfolio for sonelokimab (SLK), a tri-specific nanobody designed to inhibit IL-17A...

Futures Slide As Renewed Tariff Turmoil Shakes Global Markets

Futures Slide As Renewed Tariff Turmoil Shakes Global Markets Stock futures slumped after Trump's weekend tariff tantrum added uncertainty to American trade policy and was another blow to bullish...

<ul class="summary-bullets"><li>President Donald Trump announced over the weekend that global tariffs would rise from 10% to 15%.&nbsp;</li><li>Traders are also watching last-ditch nuclear negotiations with Iran scheduled in Geneva later this week.&nbsp;</li><li>Nvidia earnings later this week could define the next leg of the market.</li></ul>U.S. stock futures were sharply lower early Monday as investors grappled with a renewed tariff uncertainty, rising geopolitical tensions with Iran, and awaited Nvidia's big earnings report later this week. Last week’s momentum is being tested by President Donald Trump’s announcement over the weekend of a hike in global tariffs from 10% to 15%, which came a day after the Supreme Court struck it down as ‘anti-American.’The markets are also watching last-ditch nuclear talk attempts with Iran in Geneva this Thursday, amidst reports that the U.S. is considering significant military action if diplomacy fails.&nbsp;As of 3:00 a.m. ET on Monday, Nasdaq futures fell 0.6%, the S&amp;P 500 and Dow futures declined 0.5%, while Russell 2000 futures were down nearly 1%.Meanwhile, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, has moved to ‘bearish’ from ‘neutral’ last week, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq 100 Index, has remained ‘bearish’ amid high message volumes.&nbsp;On the other hand, precious metals have seen a breakout, with gold rising above $5,100 and silver nearing $88/oz.&nbsp;Trending Stocks To WatchNvidia (NVDA):&nbsp;The chip giant reports earnings on Feb 25. Beyond its guidance, all eyes will be on its commentary on AI hype, investments, and sustainability.Netflix (NFLX):&nbsp;The stock is facing potential downward pressure after President Trump threatened consequences if board member Susan Rice is not removed. This adds another layer of uncertainty as it pursues its bid for Paramount Skydance (PSKY).&nbsp;Honeywell (HON):&nbsp;It has entered into an amended deal to acquire Johnson Matthey’s Catalyst Technologies business for $1.8 billion.Vanda Pharmaceuticals (VNDA):&nbsp;The US FDA has approved Bysanti for bipolar I disorder and schizophrenia.Moonlake Immunotherapeutics (MLTX):&nbsp;Positive Phase 2 data for its spinal disease drug have led to strong after-hours gains. Traders will be watching this stock closely as we head into a new week.&nbsp;Immunity Bio (IBRX):&nbsp;This biotech stock continues to garner retail attention. Executive chairman Patrick Soon-Shiong&nbsp;<a href="http://stocktwits.com/news-articles/markets/equity/ibrx-stock-open-week-on-high-chairman-teases-anktiva-3-year-expansion-plans-cancer-breakthrough/cZRtSeQR4Us">teased</a> a detailed three-year expansion roadmap, with a detailed press release expected on Monday.&nbsp;Deere &amp; Co (DE):&nbsp;One of the most actively traded stocks last week saw a downgrade to ‘Underperform’ from Jefferies, with a target price of $550. The analyst believes it is already ‘discounted a full recovery’ and trades at steep valuations.&nbsp;Rolls-Royce (RYCEY): The company is reportedly preparing a buyback program of up to €1.5 billion.Other tickers trending on Stocktwits at the time of writing included Capricor Therapeutics (CAPR), Kraft Heinz Co (KHC), Oklo Inc (OKLO), and Ardelyx (ARDX), among others.&nbsp;Other Catalysts To WatchOn the economic front, investors will be monitoring the release of factory orders at 10:00 am ET. They will also be watching for commentary from Fed Governor Christopher Wallace before the bell today.&nbsp;On the earnings radar, investors will be watching for the quarterly reports from Domino’s Pizza (DPZ), GeneDX (WGS), Freshpet (FRPT), and Dominion Energy (D), among others, before the bell&nbsp;today. Also watch out for Hims &amp; Hers (HIMS), Keysite Technologies (KEYS), and Diamonback Energy (FANG) that report after market close.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com

Nasdaq, S&P 500 Futures Fall On Tariff, Iran Tensions: Why NVDA, NFLX, HON, IBRX, MLTX Are On Traders' Radar Today

Data from Stocktwits indicated retail sentiment on SPY and QQQ has been ‘bearish’. 

Equity

Data from Stocktwits indicated retail sentiment on SPY and QQQ has been ‘bearish’. 


<ul class="summary-bullets"><li>Phase 2 S-OLARIS trial data showed 81% of patients improved within 12 weeks, meeting the primary endpoint.</li><li>Imaging and biomarker results confirming reduced spine inflammation, while no new safety issues were identified.</li><li>MoonLake enters Investor Day with funding in place into the second half of 2027, supported by $394 million in cash.</li></ul>Shares of MoonLake Immunotherapeutics, Inc. (MLTX) surged over 10% in overnight trading on Sunday ahead of Monday’s Investor Day, as newly released clinical data for its experimental spine disease drug reignited investor interest after a volatile year marked by a major setback.<a href="https://stocktwits.com/symbol/MLTX">MLTX stock</a> jumped over 3% on Friday to hit $18.77, but ended 0.3% lower in after-hours trading.&nbsp;<h2 class="st-heading-2">Phase 2 Trial In Spine Disease Meets Primary Endpoint&nbsp;</h2>On Sunday, the company reported positive topline results from a Phase 2 clinical trial of Sonelokimab (SLK) in patients with axial spondyloarthritis, a chronic inflammatory disease that causes severe back pain, stiffness, and progressive loss of mobility.&nbsp;MoonLake said its Phase 2 S-OLARIS trial showed that 81% of patients treated with SLK saw clear improvement in their condition within 12 weeks. The trial met its primary endpoint, using the same standard doctors and regulators rely on to judge whether new treatments for this disease reduce pain, inflammation, and limits on daily movement.MoonLake reported that more than 80% of patients also showed clinically important improvement on additional disease activity measures by Week 12. These clinical gains were supported by imaging results, with MRI scans showing reductions in inflammation inside affected joints.PET imaging further showed a reduction in both inflammation and osteoblast activity within the sacroiliac joints by Week 12. Osteoblast activity is a key driver of irreversible bone formation and progressive loss of mobility in axial spondyloarthritis. Tests on patients’ blood and tissue showed that the drug quickly and consistently reduced the inflammation signals that drive the disease to worsen over time.The company said the safety profile of SLK in the S-OLARIS trial was consistent with previous studies and that no new safety signals were identified.&nbsp;<h2 class="st-heading-2">Cash Position Extends Runway Into 2027</h2>MoonLake reported that it ended 2025 with $394 million in cash, cash equivalents, and short-term marketable securities. The company said this, combined with proceeds from a recent $75 million equity raise, is expected to fund operations into the second half of 2027.The company also announced an amended debt facility with Hercules Capital, including a $25 million drawdown and up to $400 million in additional non-dilutive funding available to support future needs.<h2 class="st-heading-2">Why The Data Matters&nbsp;</h2>The Phase 2 readout marks a positive development for MoonLake following a sharp selloff in September 2025, when one of its Phase 3 trials in a separate skin disease indication failed to meet its primary endpoint. That result triggered a roughly 90% collapse in the stock price over two sessions and sparked a securities class-action lawsuit filed in December.MoonLake will host its&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mltx-stock-heads-into-investor-day-with-fda-momentum/cZRjp7xR4wl">Investor Day</a> on Feb. 23, with presentations from its CEO, chief scientific officer, and CFO, followed by an open Q&amp;A session. The company will also discuss the outcomes of its recent Type B meeting with the U.S. Food and Drug Administration (FDA) regarding hidradenitis suppurativa, including next steps related to label strategy and the planned biologics license application submission.&nbsp;Additionally, the company plans to share an interim analysis of the continued response to SLK beyond Week 16 from the Phase 3 Vela trials in adult patients with hidradenitis suppurativa, as well as interim data from the Vela-Teen Phase 3 trial in adolescent patients.MoonLake said the Investor Day will also include an update on its financial position and a review of key 2026 catalysts. These include upcoming data releases from the Phase 3 Izar trials in psoriatic arthritis, as well as the planned Phase 3 development program in palmoplantar pustulosis.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for MLTX was ‘extremely bullish’ amid ‘extremely high’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/mltx_ss_png_34534e245f.webp" alt="mltx ss.png" width="961" height="144"><figcaption>MLTX sentiment and message volume as of February 22 | Source: Stocktwits</figcaption></figure>One user said, “I didn't think were were getting the financials until Wednesday. &nbsp; Looks very positive to me.&nbsp; Tomorrow should be epic, shorts might wanna cover ASAP.”<stembedurl>https://stocktwits.com/DerekVtx/message/645569026</stembedurl>Another user said, “Today had amazing news, tomorrow morning will have many announcements but there are many more to follow. This is like top 10 roadmaps for any drug company right now”&nbsp;<stembedurl>https://stocktwits.com/LouKojak/message/645565865</stembedurl>MLTX stock has risen 42% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the MoonLake Immunotherapeutics (Moon Lake) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

MLTX Stock Jumps Over 10% Overnight As Spine Drug Trial Win Sets Stage For Investor Day Showdown

 Investors are now turning to Monday’s Investor Day for regulatory clarity, pipeline updates, and key 2026 catalysts.

MoonLake Immunotherapeutics (NASDAQ:MLTX) Given New $12.00 Price Target at Royal Bank Of Canada

Royal Bank Of Canada boosted their price target on shares of MoonLake Immunotherapeutics from $10.00 to $12.00 and gave the stock a "sector perform" rating in a research note on Friday...

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.89	--	--	N/A
Q4 '25	-$0.97	--	--	N/A
Q3 '25	-$0.88	-$1.10	-25.17%	MISSED
Q2 '25	-$0.71	-$0.87	-21.82%	MISSED
Q1 '25	-$0.75	-$0.63	16.44%	BEAT

MLTX
MoonLake Immunotherapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest MLTX News

MLTXMoonLake Immunotherapeutics